BioSpace News Archive

Business

Andrea Hartong, CNOR, CLNC is Elected to the American Health Council’s Nurse Board

The American Health Council proudly announces the election of Andrea Hartong, CNOR, CLNC to their Nursing Board for her examples of healthcare excellence.

August 3, 2018
·
3 min read
Drug Development

RedHill Biopharma Elaborates on Its Announced Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease

RedHill Biopharma Ltd. today elaborated on the previously announced positive top-line results from the first Phase III study with orally-administered RHB-104 for Crohn’s disease (the MAP US study).

August 3, 2018
·
11 min read
The Qt Company and MedAcuity Announce Partnership to Accelerate Medical Device Companies’ Time-to-Market

Today, the Qt Companyannounced a new partnership with MedAcuity, the go-to US-based software development partner for leading MedTech companies, to help clients accelerate time-to-market for their medical device products.

August 3, 2018
·
2 min read
BioForest

Naturopathic Doctors Offer Non-Drug Approaches to Manage HypertensionApproximately 103 Million American Adults Have High Blood Pressure

New guidelines from the American Heart Association mean that nearly one out of every two American adults with high blood pressure may be facing a choice about prescription drug treatment.

August 3, 2018
·
2 min read
BioCapital

Study Reveals Non-Emergency Medical Transportation (NEMT) is Extremely Cost-Effective and Life-Saving to Medicaid ProgramMore than $40 Million ROI Per Month Found in Study Population Alone

For more than 40 years, Medicaid beneficiaries, many of whom are among our nation’s most fragile citizens, have relied on non-emergency medical transportation (NEMT) for travel to and from medical appointments.

August 3, 2018
·
5 min read
Business

Immune Design Reports Second Quarter 2018 Financial Results and Provides Corporate Update

G100 advancing to late-stage development following FDA feedback

August 3, 2018
·
10 min read
Deals

BioCryst Pharmaceuticals Commences Public Offering of $50 Million of Its Common Stock

BioCryst Pharmaceuticals, Inc. announced that it is offering to sell $50 million of its common stock in an underwritten public offering.

August 3, 2018
·
3 min read
Drug Development

Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline

Dosed First Patient in Cohort 3 in the ADVANCE Phase 1/2 Trial of ADVM-043

August 3, 2018
·
10 min read
Business

Globus Medical Reports Second Quarter 2018 Results

Globus Medical, Inc. announced its financial results for the second quarter ended June 30, 2018.

August 3, 2018
·
17 min read
Deals

BioCryst Pharmaceuticals Prices Public Offering of 9,090,910 Shares of Its Common Stock

BioCryst Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock, offered at a price to the public of $5.50 per share.

August 3, 2018
·
3 min read